Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Regulatory Filings 2021

Jun 29, 2021

59255_rns_2021-06-29_b01dfc6d-d316-4a9a-9dd4-59347d44d5e0.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 31] intentionally omitted <==

28[th] June, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**CompanyScripCode: 532834|To,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)

Dear Sir/Madam,

The trading window under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 will be closed from July 1, 2021 till the end of 48 hours after the declaration of financial results for the quarter ended June 30, 2021.

Kindly take the above information on records.

Thanking You, For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [84 x 34] intentionally omitted <==

Mr. Mandar Godbole GM Legal, Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==